Sophie Bersoux1, Curtiss B Cook2, Gail L Kongable3, Jianfen Shu3, Denise R Zito4. 1. Division of Community Internal Medicine, Mayo Clinic, Scottsdale, Arizona. 2. Division of Endocrinology and Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Scottsdale, Arizona. 3. The Epsilon Group, Charlottesville, Virginia. 4. Alere Informatics Solutions, Charlottesville, Virginia.
Abstract
OBJECTIVE: Report data on glucose control from 635 U.S. hospitals. METHODS: Point-of-care blood glucose (POC-BG) test data from January through December 2012 from 635 facilities were extracted. Glucose control was evaluated using patient-day-weighted mean POC-BG values. We calculated hypoglycemia and hyperglycemia rates, stratified by presence or absence of intensive care unit (ICU) admission, and we evaluated the relationship between glycemic control and hospital characteristics. RESULTS: In total, 51,375,764 POC-BG measurements (non-ICU, 39,197,762; ICU, 12,178,002) from 2,612,966 patients (non-ICU, 2,415,209; ICU, 575,084) were analyzed. The mean POC-BG was 167 mg/dL for non-ICU patients and 170 mg/dL for ICU patients. The prevalence of hyperglycemia (defined as glucose value >180 mg/dL) was 32.3 and 28.2% in non-ICU and ICU patients, respectively. The prevalence of hypoglycemia (defined as glucose value <70 mg/dL) was 6.1 and 5.6% in non-ICU and ICU patients, respectively. In non-ICU and ICU settings, the patient-day-weighted mean glucose was highest in the smallest hospitals, in rural hospitals, and in hospitals located in the Northeast (all P<.01). For non-ICU patients, we observed a significant difference in the percentage of patient days with hypoglycemia by geographic region only (P<.001). In ICU patients, the prevalence of hypoglycemia varied significantly by hospital type (P<.03) and geographic region (P<.01). CONCLUSION: In this largest POC-BG data set analysis conducted to date, glycemic control varied according to hospital characteristics. Our findings remain consistent with previous reports. Among other variables, national benchmarking of inpatient glucose data will need to consider differences in hospital characteristics.
OBJECTIVE: Report data on glucose control from 635 U.S. hospitals. METHODS: Point-of-care blood glucose (POC-BG) test data from January through December 2012 from 635 facilities were extracted. Glucose control was evaluated using patient-day-weighted mean POC-BG values. We calculated hypoglycemia and hyperglycemia rates, stratified by presence or absence of intensive care unit (ICU) admission, and we evaluated the relationship between glycemic control and hospital characteristics. RESULTS: In total, 51,375,764 POC-BG measurements (non-ICU, 39,197,762; ICU, 12,178,002) from 2,612,966 patients (non-ICU, 2,415,209; ICU, 575,084) were analyzed. The mean POC-BG was 167 mg/dL for non-ICU patients and 170 mg/dL for ICU patients. The prevalence of hyperglycemia (defined as glucose value >180 mg/dL) was 32.3 and 28.2% in non-ICU and ICU patients, respectively. The prevalence of hypoglycemia (defined as glucose value <70 mg/dL) was 6.1 and 5.6% in non-ICU and ICU patients, respectively. In non-ICU and ICU settings, the patient-day-weighted mean glucose was highest in the smallest hospitals, in rural hospitals, and in hospitals located in the Northeast (all P<.01). For non-ICU patients, we observed a significant difference in the percentage of patient days with hypoglycemia by geographic region only (P<.001). In ICU patients, the prevalence of hypoglycemia varied significantly by hospital type (P<.03) and geographic region (P<.01). CONCLUSION: In this largest POC-BG data set analysis conducted to date, glycemic control varied according to hospital characteristics. Our findings remain consistent with previous reports. Among other variables, national benchmarking of inpatient glucose data will need to consider differences in hospital characteristics.
Authors: Elias K Spanakis; David L Levitt; Tariq Siddiqui; Lakshmi G Singh; Lillian Pinault; John Sorkin; Guillermo E Umpierrez; Jeffrey C Fink Journal: J Diabetes Sci Technol Date: 2017-12-13
Authors: Robert J Rushakoff; Joshua A Rushakoff; Zachary Kornberg; Heidemarie Windham MacMaster; Arti D Shah Journal: Curr Diab Rep Date: 2017-09 Impact factor: 4.810
Authors: Saumeth Cardona; Patricia C Gomez; Priyathama Vellanki; Isabel Anzola; Clementina Ramos; Maria A Urrutia; Jeehea Sonya Haw; Maya Fayfman; Heqiong Wang; Rodolfo J Galindo; Francisco J Pasquel; Guillermo E Umpierrez Journal: BMJ Open Diabetes Res Care Date: 2018-12-18
Authors: Martin McDonnell; Richard J Harris; Florina Borca; Tilly Mills; Louise Downey; Suranga Dharmasiri; Mayank Patel; Benjamin Zare; Matt Stammers; Trevor R Smith; Richard Felwick; J R Fraser Cummings; Hang T T Phan; Markus Gwiggner Journal: BMJ Open Gastroenterol Date: 2020-11
Authors: David C Klonoff; Jordan Messler; Timothy Valk; Ram Jagannathan; Francisco J Pasquel; Guillermo E Umpierrez Journal: J Diabetes Sci Technol Date: 2021-06-23